Study at Cambridge
About the University
Research at Cambridge
Mobile menu
Mobile menu
Privacy
Cookies
Accessibility
Search
About
About
Our team
Our performance
Careers
The Cambridge ecosystem
Partnerships and collaboration
back
For the University
For the University
Tell us your idea
Be a consultant
Develop a commercial opportunity
Start a company or social venture
Develop your skills & network
Cambridge Enterprise Academic Portal
back
For external organisations
For external organisations
Find a consultant
Opportunities to invest
International outreach
Available technologies
Available research tools
Experts & Mentors Programme
back
Latest
Latest
News
Insights
Case studies
Videos
back
What’s on
Contact us
Posts Tagged ‘cancer’
cancer
Share:
Spin-outs
31 January 2024
Caring for cancer patients
Find out more
Spin-outs
15 November 2023
Next-gen cancer therapies lands £48 million for T-Therapeutics
Find out more
Life Sciences
30 June 2020
Cambridge spin-out PharmEnable raises £1.8m for drug discovery expansion
Find out more
Spin-outs
27 February 2020
PolyProx Therapeutics: a new class of drugs to halt difficult-to-drug cancers
Find out more
Life Sciences
3 October 2016
Cambridge Enterprise joins largest-ever early stage investment in a UK university spin-out
Find out more
Life Sciences
10 March 2016
PhoreMost and The Wistar Institute collaborate to identify new druggable targets
Find out more
Life Sciences
24 January 2016
Drugging the undruggable
Find out more
Life Sciences
8 April 2015
PhoreMost raises £2.5m to identify new targets for therapeutics
Find out more
Life Sciences
23 September 2014
Inivata raises £4m to improve cancer treatment through simple blood tests
Find out more
Life Sciences
9 January 2014
Rewiring stem cells aids understanding of medical conditions
Find out more
Life Sciences
20 December 2013
Breaking down pancreatic cancer defence mechanisms
Find out more
Life Sciences
12 December 2013
Sequencing: How large is the alphabet of DNA?
Find out more
1
2
Sign up to our newsletter
Stay in touch with the latest updates from Cambridge Enterprise
Sign up now